LGR5 and cholangiocarcinoma: GPR55 mRNA showed a significant negative correlation with the other biomarker mRNAs, except for LGR5 mRNA, in stage IV lymph nodes, a finding which is expected because GPR55 is not expressed or expressed at very low levels in CC tumor cells (see above).